Search Results 51-60 of 261 for ❣010라인인증 TG@KORID010 010어플가입인증❣

1. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

   The purpose of this study is to assess the effect of TAK-411 on disability in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

2. A Study Using Targeted Inhibitors to Treat Specific Tumor Mutations in Patients with Meningiomas - Mayo Clinic

   This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

3. A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. A Study to Evaluate INO-3107 with Electroporation (EP) in Participants with HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness, safety, tolerability and immunogenicity (ability to produce immune response) of INO-3107 in ...

5. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   This randomized phase II clinical trial studies how well nivolumab after combined modality therapy works in treating patients with high risk stage II-IIIB anal ...

6. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy ... line therapy) but have residual disease.

7. A Phase I Study of MSB2311 in Advanced Solid Tumors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   The primary objective of Phase 3 is to evaluate progression-free survival (PFS) for subjects receiving first-line CMP-001 in combination with nivolumab versus ...

9. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency - Mayo Clinic

   The purpose of this study (Study INZ701-304 [ADAPT])) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ...

10. Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score - Mayo Clinic

    Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling ...